tradingkey.logo

Apyx Medical Corp

APYX
3.880USD
-0.060-1.52%
종가 02/06, 16:00ET시세는 15분 지연됩니다
146.74M시가총액
손실P/E TTM

Apyx Medical Corp

3.880
-0.060-1.52%

자세한 내용은 Apyx Medical Corp 회사

Apyx Medical Corporation is an advanced energy technology company. The Company's segments include Advanced Energy and Original Equipment Manufacturer (OEM). The Advanced Energy segment's product portfolio consists of Helium Plasma Technology, which is marketed and sold as Renuvion in the cosmetic surgery market, and J-Plasma in the hospital surgical market. It focuses on the cosmetic surgery market, where Renuvion offers plastic surgeons, facial plastic surgeons and cosmetic physicians the ability to provide controlled heat to the tissue to achieve their desired results. These product lines consist of a multifunction generator, a handpiece and a supply of helium gas. Through OEM agreements, the OEM segment produces generators, medical devices, and related accessories for medical device manufacturers as well as start-up businesses in need of its energy-based designs. It specializes in the design, development, and manufacturing of electrosurgical equipment and medical devices.

Apyx Medical Corp 정보

종목 코드 APYX
회사 이름Apyx Medical Corp
상장일Jul 22, 1983
CEOGoodwin (Charles D)
직원 수220
유형Ordinary Share
회계 연도 종료Jul 22
주소5115 Ulmerton Rd
도시CLEARWATER
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호33760-4004
전화18005372790
웹사이트https://apyxmedical.com/
종목 코드 APYX
상장일Jul 22, 1983
CEOGoodwin (Charles D)

Apyx Medical Corp의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Mr. Stavros G. Vizirgianakis
Mr. Stavros G. Vizirgianakis
Independent Chairman of the Board
Independent Chairman of the Board
1.75M
--
Mr. Moshe Citronowicz
Mr. Moshe Citronowicz
Senior Vice President
Senior Vice President
456.50K
--
Mr. Lawrence J. (Larry) Waldman, CPA
Mr. Lawrence J. (Larry) Waldman, CPA
Lead Independent Director
Lead Independent Director
42.90K
--
Mr. Matthew C. (Matt) Hill
Mr. Matthew C. (Matt) Hill
Chief Financial Officer, Treasurer, Secretary
Chief Financial Officer, Treasurer, Secretary
8.50K
--
Mr. Charles D. Goodwin, II
Mr. Charles D. Goodwin, II
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Minnie Baylor-Henry, J.D.
Ms. Minnie Baylor-Henry, J.D.
Independent Director
Independent Director
--
--
Ms. Wendy Levine
Ms. Wendy Levine
Independent Director
Independent Director
--
--
Mr. Shawn David Roman
Mr. Shawn David Roman
Chief Operating Officer
Chief Operating Officer
--
--
이름
이름/직위
직위
주식 보유
변동
Mr. Stavros G. Vizirgianakis
Mr. Stavros G. Vizirgianakis
Independent Chairman of the Board
Independent Chairman of the Board
1.75M
--
Mr. Moshe Citronowicz
Mr. Moshe Citronowicz
Senior Vice President
Senior Vice President
456.50K
--
Mr. Lawrence J. (Larry) Waldman, CPA
Mr. Lawrence J. (Larry) Waldman, CPA
Lead Independent Director
Lead Independent Director
42.90K
--
Mr. Matthew C. (Matt) Hill
Mr. Matthew C. (Matt) Hill
Chief Financial Officer, Treasurer, Secretary
Chief Financial Officer, Treasurer, Secretary
8.50K
--
Mr. Charles D. Goodwin, II
Mr. Charles D. Goodwin, II
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Minnie Baylor-Henry, J.D.
Ms. Minnie Baylor-Henry, J.D.
Independent Director
Independent Director
--
--

수익 분석

통화: USD마지막 업데이트: Tue, Jan 6
통화: USD마지막 업데이트: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
기업이 아직 관련 데이터를 공개하지 않았습니다.
지역별USD
이름
수익
비율
Domestic
9.33M
72.47%
International
3.54M
27.53%
사업별
지역별
기업이 아직 관련 데이터를 공개하지 않았습니다.

주식 보유 통계

마지막 업데이트: Wed, Feb 4
마지막 업데이트: Wed, Feb 4
주주
주주 유형
주주
주주
비율
Nantahala Capital Management, LLC
8.14%
Archon Capital Management LLC
8.00%
Vanderfelt (William Weeks)
7.70%
Royce Investment Partners
5.96%
Vizirgianakis (Stavros G)
4.26%
기타
65.95%
주주
주주
비율
Nantahala Capital Management, LLC
8.14%
Archon Capital Management LLC
8.00%
Vanderfelt (William Weeks)
7.70%
Royce Investment Partners
5.96%
Vizirgianakis (Stavros G)
4.26%
기타
65.95%
주주 유형
주주
비율
Hedge Fund
17.02%
Individual Investor
13.42%
Investment Advisor
12.29%
Investment Advisor/Hedge Fund
8.92%
Private Equity
2.33%
Family Office
0.19%
Research Firm
0.10%
Venture Capital
0.05%
기타
45.69%

기관 주식 보유

마지막 업데이트: Mon, Dec 8
마지막 업데이트: Mon, Dec 8
보고 기간
기관 수
보유 주식
비율
변동
2025Q4
93
15.65M
47.11%
--
2025Q3
106
16.17M
54.10%
-179.30K
2025Q2
111
16.35M
54.58%
+38.20K
2025Q1
115
16.92M
61.27%
-6.24M
2024Q4
121
17.05M
55.05%
+3.13M
2024Q3
126
13.93M
65.05%
-228.66K
2024Q2
141
15.10M
68.01%
-305.66K
2024Q1
168
15.41M
70.58%
-9.04M
2023Q4
180
18.49M
72.63%
-941.37K
2023Q3
175
19.43M
74.54%
-988.75K
더 보기

주주 활동

이름
보유 주식
비율
변동
Chg %
날짜
Nantahala Capital Management, LLC
3.34M
8.14%
--
--
Sep 30, 2025
Archon Capital Management LLC
3.28M
8%
--
--
Sep 30, 2025
Vanderfelt (William Weeks)
3.16M
7.7%
--
--
Jun 23, 2025
Royce Investment Partners
2.47M
6.03%
+34.70K
+1.42%
Sep 30, 2025
Vizirgianakis (Stavros G)
1.75M
4.26%
--
--
Jun 23, 2025
The Vanguard Group, Inc.
1.53M
3.73%
+53.17K
+3.60%
Sep 30, 2025
Silverberg Bernstein Capital Management, LLC
986.50K
2.41%
+89.77K
+10.01%
Sep 30, 2025
Commonwealth Financial Network
663.54K
1.62%
--
--
Sep 30, 2025
Horizon Kinetics LLC
615.00K
1.5%
--
--
Sep 30, 2025
더 보기

관련 ETF

마지막 업데이트: Sat, Dec 6
마지막 업데이트: Sat, Dec 6
이름
비율
iShares Micro-Cap ETF
0.02%
Avantis US Equity ETF
0%
Avantis US Small Cap Equity ETF
0%
iShares Micro-Cap ETF
비율0.02%
Avantis US Equity ETF
비율0%
Avantis US Small Cap Equity ETF
비율0%

주식 배당금

지난 5년 동안 총 0.00 USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음

주식 분할

날짜
배당락일
유형
비율
데이터 없음
날짜
배당락일
유형
비율
데이터 없음
KeyAI